期刊文献+

免疫治疗妊娠合并急性炎性脱髓鞘性多发神经根神经病 被引量:1

Immunotherapy of pregnancy complicating acute inflammatory demyelinating polyneuropathie
下载PDF
导出
摘要 目的探讨免疫治疗妊娠合并急性炎性脱髓鞘性多发神经根神经病(acute inflammatory demyelinating polyneuropathies,AIDP)的疗效和母婴预后。方法回顾性分析南开大学附属第四中心医院2010年8月至2018年1月收治的45例妊娠合并AIDP的患者资料。依据免疫治疗方式将入组患者分为静脉注射免疫球蛋白(intravenous immunoglobulin,IVIg)组和血浆置换(plasma exchange,PE)组。对比分析两组患者免疫治疗的疗效和母婴预后。结果IVIg组25例,PE组20例。IVIg组和PE组治疗有效率分别为84.0%(21/25)和85.0%(17/20),机械通气率分别为12.0%(3/25)和15.0%(3/20),病死率分别为4.0%(1/25)和5.0%(1/20),差异均无统计学意义(P>0.05)。IVIg组和PE组的治疗显效时间分别为(5.0±1.0)d和(7.1±3.4)d(t=-2.825,P=0.010),好转时间分别为(9.5±1.3)d和(10.0±1.6)d(t=-1.111,P=0.603),基本治愈时间分别为(14.1±1.8)d和(17.1±2.8)d(t=-3.875,P=0.071),临床治愈时间分别为(22.7±4.7)d和(22.4±6.9)d(t=0.136,P=0.159)。IVIg最常见的并发症是荨麻疹4例(P=0.561)、一过性发热3例(P=0.418)和头痛3例(P=0.418)。PE组最常见的并发症是低钙血症5例(P=0.042)和电解质紊乱5例(P=0.042)。43例患者随访1年无吉兰-巴雷综合征(GBS)复发。婴儿均体健、无先天畸形的发生。结论IVIg和PE治疗妊娠合并AIDP总体安全、有效。母婴多预后良好。 Objective To explore the immunotherapy and prognosis of pregnancy complicating acute inflammatory demyelinating polyneuropathies(AIDP).Methods The clinical data of 45 hospitalized pregnancy complicating AIDP patients recruited from August 2010 to January 2018 at the the Nankai University Affiliated Tianjin Fourth Central Hospital were collected and analyzed retrospectively,and patients were divided into the intravenous immunoglobulin(IVIg)group and plasma exchange(PE)group.The immunotherapy and prognosis were compared between the two groups.Results The efficiency of IVIg group(25 cases)and PE group(23 cases)was 84.0%(21/25)and 85.0%(17/20),mechanical ventilation was 12.0%(3/25)and 15.0%(3/20),and the mortality was 4.0%(1/25)and 5.0%(1/20),respectively.The effective time of IVIg group and PE group was(5.0±1.0)d and(7.1±3.4)d(t=-2.825,P=0.010),the improvement time was(9.5±1.3)d and(10.0±1.6)d(t=-1.111,P=0.603),the basic cure time was(14.1±1.8)d and(17.1±2.8)d(t=-3.875,P=0.071),and the cure time was(22.7±4.7)d and(22.4±6.9)d(t=0.136,P=0.159),respectively.The most common complications of IVIg were urticaria(4 cases,P=0.042),transient fever(3 cases,P=0.418)and headache(3 cases,P=0.418).The most common complications in the PE group were hypocalcemia(5 cases,P=0.042)and electrolyte disturbance(5 cases,P=0.042).43 patients were followed up for 1 year without recurrence of GBS.The infants were healthy and had no congenital malformation.Conclusions IVIg and PE is generally safe and effective.The prognosis of maternal and infant is generally good.
作者 谷亚伟 张利霞 梁雪梅 赵岚 范宏光 王利军 GU Ya- wei;ZHANG Lixia;LIANG Xuemei;ZHAO Lan;FAN Hongguang;WANG Lijun(Department of Neurology,Nankai University Affiliated Tianjin Fourth Central Hospital,Tianjin 300140,China)
出处 《实用医学杂志》 CAS 北大核心 2019年第17期2775-2779,共5页 The Journal of Practical Medicine
关键词 妊娠 急性炎性脱髓鞘性多发神经根神经病 免疫治疗 预后 pregnancy acute inflammatory demyelinating polyneuropathies immunotherapy prognosis
  • 相关文献

参考文献2

二级参考文献14

  • 1Hiraga A,Mori M,Ogawara K,et al.Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes.Neurology,2003,61:471-474.
  • 2Kuwabara S.Guillain-Barré syndrome:epidemiology,pathophysiology and management.Drugs,2004,64:597-610.
  • 3van Doorn PA,Ruts L,Jacobs BC.Clinical features,pathogenesis,and treatment of Guillain-Barré syndrome.Lancet Neurol,2008,7:939-950.
  • 4Lunn MP,Willison HJ.Diagnosis and treatment in inflammatory neuropathies.J Neurol Neurosurg Psychiatry,2009,80:249-258.
  • 5Kuwabara S,Ogawara K,Misawa S,et al.Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome?Neurology,2004,63:529-533.
  • 6Asbury AK,Cornblath DR.Assessment of current diagnostic criteria for Guillain-Barré syndrome.Ann Neurol,1990,27Suppl:S21 -S24.
  • 7Van den Bergh PY,Pié ret F.Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.Muscle Nerve,2004,29:565-574.
  • 8Hiraga A,Mori M,Ogawara K,et al.Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome.J Neurol Neursurg Psychiatry,2005,76:719-722.
  • 9Van der Meché FG,Van Doorn PA,Meulstee J,et al.Diagnostic and classification criteria for the Guillain-Barré syndrome.Eur Neurol,2001,45:133-139.
  • 10Overell JR,Willison HJ.Recent developments in Miller Fisher syndrome and related disorders.Curr Opin Neurol,2005,18:562-566.

共引文献238

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部